Carson v. Berryhill

286 F. Supp. 3d 818
District Court, S.D. Texas·Decided January 26, 2018·No. CIVIL ACTION NO. H–17–199·Published·Cited by 2 cases

Opinion

Nancy K. Johnson, U.S. MAGISTRATE JUDGE

Pending before the court2 are Plaintiff's Motion for Summary Judgment (Doc. 10) and Defendant's Cross-Motion for Summary Judgment (Doc. 7). The court has considered the motions, the responses, the administrative record, and the applicable law. For the reasons set forth below, the court RECOMMENDS that Plaintiff's motion be DENIED and Defendant's motion be GRANTED .

I. Case Background

Plaintiff filed this action pursuant to 42 U.S.C. § 405(g) for judicial review of an unfavorable decision by the Social Security Administration ("SSA") Commissioner ("Commissioner" or "Defendant") regarding Plaintiff's claim for disability insurance benefits under Title II of the Social Security Act ("Act").

*821A. Medical History

Plaintiff was born on May 26, 1961, and was fifty-one years old on the alleged disability onset date of May 14, 2013.3 Plaintiff worked as a court reporter for many years up to May 14, 2013.4 The medical records generally support a history of treatment for psychiatric disorders and diabetes mellitus ("diabetes").5

1. Psychiatric Disorders

Plaintiff began treatment with Edward Fallick, D.O., ("Dr. Fallick") in 2000 for psychiatric disorders.6 At an appointment four months prior to the alleged onset date, Plaintiff reported that she was feeling much better since starting Abilify,7 stating that it "[r]eally changed [her] life" and that her mood was a lot lighter and she was "less snappish."8 During the relevant time, Plaintiff continued to see Dr. Fallick for medication management until January 2015.9 At that last appointment, Plaintiff stated that she was "[d]oing fairly well (all things considered)."10 Although Plaintiff's mood reports varied from increased depression to improved, the mental status examination results were consistently within normal limits, and the Global Assessment of Functioning11 ("GAF") score, when included, remained at sixty, a score at the highest functioning end of moderate symptoms.12 Dr. Fallick diagnosed Plaintiff with mood disorder, not otherwise specified, and regularly adjusted Plaintiff's medications based on Plaintiff's reports of the effects on her mood.13 None of Dr. Fallick's treatment notes from this time period reflected a diagnosis of bipolar disorder or attention-deficit hyperactivity disorder ("ADHD") or recorded any cognitive side effects from medication.14 They also provided no indication of Plaintiff's residual functional capacity or her limitations of daily living, other than the mention that Plaintiff lacked motivation and that she was not going out of the house for certain periods.15

In March 2014, Plaintiff began receiving treatment through the Harris Health System for both medication management and psychotherapy.16 Cristin Aoshima-Kilroy, M.D., ("Dr. Aoshima-Kilroy") performed the initial psychiatric evaluation on March 4, 2014, and found Plaintiff's mental status examination to be within normal limits with "ok" mood and "full range-dysthymic"

*822affect.17 Dr. Aoshima-Kilroy expressed her concern with the number of psychotropic medications that Plaintiff was taking and her opinion that Plaintiff's self-reported cognitive blunting and headaches could be a result of the medications.18 The doctor discussed these points with Plaintiff, who said that she wanted to remain on all of the medications.19

Diagnosing Plaintiff with mood disorder, not otherwise specified, Dr. Aoshima-Kilroy stated, "I do not see enough evidence to agree with diagnosis of bipolar disorder. Borderline personality disorder appears to be better suited diagnosis and will continue to monitor for this."20 Dr. Aoshima-Kilroy added cluster B traits to Plaintiff's diagnosis, reflecting the opinion that Plaintiff could have a personality disorder.21

Over the course of the subsequent seventeen months, Plaintiff attended eleven medication management appointments with Dr. Aoshima-Kilroy, who consistently recorded that the mental status examinations were within normals limits with changes in mood that ranged in description from depressed to anxious to "better" to "accepting" and affect that mostly remained dysthymic.22 Dr. Aoshima-Kilroy continued the diagnosis of mood disorder and cluster B traits throughout treatment during the relevant time but added the diagnosis of anxiety disorder, not otherwise specified, in August 2014.23 A year later, she changed the mood disorder diagnosis to unspecified bipolar disorder and added neuro-cognitive disorder.24

Dr. Aoshima-Kilroy variously rated Plaintiff's GAF score as fifty-five or sixty, both reflecting moderate symptoms, throughout treatment.25 At various times, Plaintiff reported making jewelry, refinishing furnishing, having friends over to visit frequently, visiting a friend out of town, washing clothes and dishes, driving others around town, and attending support groups.26 Plaintiff reported memory difficulties more than once and, at one appointment, could not remember any of five objects until given a hint on one, after which she was able to name them all.27

In addition to medication management, Plaintiff received psychotherapy for anxiety and depression prior to the alleged onset date.28 The therapy sessions through Harris Health System were the only time-relevant psychotherapy in the record. From March 2014 to August 2015, Plaintiff received psychotherapy more than thirty times.29

Free access — add to your briefcase to read the full text and ask questions with AI

Carson v. Berryhill, 286 F. Supp. 3d 818 (S.D. Tex. 2018).

286 F. Supp. 3d 818 (Carson v. Berryhill) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

People v. Bendovid
California Court of Appeal, 2018
People v. Bendovid
241 Cal. Rptr. 3d 640 (California Court of Appeals, 5th District, 2018)